|
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 37978951 | Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. | J Clin Oncol | 2024 |
| 37534382 | Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors. | Pediatr Blood Cancer | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 36259971 | Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. | Cancer Discov | 2023 |
| 37603953 | Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma. | Neoplasia | 2023 |
| 36516489 | Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group. | Neoplasia | 2023 |
| 36862968 | Infantile ZFTA Fusion-Positive Tumor of the Posterior Fossa: Molecular Tumor Board. | JCO Precis Oncol | 2023 |
| 37232001 | A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors. | Pediatr Neurosurg | 2023 |
| 36599192 | Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety. | Neoplasia | 2023 |
| 34935967 | Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026). | Neuro Oncol | 2022 |
| 35866410 | The "SEED" Study: The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy with Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric and Young Adult Patients with Recurrent or Refractory Brain Tumors. | Frontiers in Bioscience - Landmark | 2022 |
| 35611273 | Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. | Neurooncol Adv | 2022 |
| 35354845 | Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor. | Sci Rep | 2022 |
| 35664557 | Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data. | Neurooncol Adv | 2022 |
| 34850169 | Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study. | Neuro Oncol | 2022 |
| 34668975 | Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. | Neuro Oncol | 2022 |
| 34435883 | Matrix Hyaluronic Acid and Hypoxia Influence a CD133 Subset of Patient-Derived Glioblastoma Cells. | Tissue Engineering - Part A. | 2022 |
| 35148393 | Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. | Neuro Oncol | 2022 |
| 35129878 | Two cases of pineal anlage tumor with molecular analysis. | Pediatr Blood Cancer | 2022 |
| 34882234 | Carboplatin During Craniospinal Radiotherapy for Children With Group 3 Medulloblastoma-A New Standard of Care?-Reply. | JAMA Oncol | 2022 |
| 34613581 | Predictors of mortality and tumor recurrence in desmoplastic infantile ganglioglioma and astrocytoma-and individual participant data meta-analysis (IPDMA). | J Neurooncol | 2021 |
| 34292305 | Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group. | JAMA Oncol | 2021 |
| 33502920 | Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. | J Clin Oncol | 2021 |
| 33378085 | Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy. | Pediatric Dermatology | 2021 |
| 32862234 | Molecularly Targeted Treatments for NF1-Mutant Diffuse Intrinsic Pontine Glioma. | J Appl Lab Med | 2021 |
| 33130903 | Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models. | Neuro Oncol | 2021 |
| 33405376 | A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). | Pediatr Blood Cancer | 2021 |
| 34409497 | Subgroup and subtype-specific outcomes in adult medulloblastoma. | Acta Neuropathol | 2021 |
| 32603316 | Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma. | J Clin Invest | 2020 |
| 32133357 | Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors. | Frontiers in Cell and Developmental Biology | 2020 |
| 32923898 | Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition. | JCO Precis Oncol | 2020 |
| 32523649 | Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002). | Oncotarget | 2020 |
| 32743560 | Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma. | Cell Rep Med | 2020 |
| 32506137 | MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. | Neuro Oncol | 2020 |
| 31123753 | Differential trajectories of neurocognitive functioning in females versus males following treatment for pediatric brain tumors. | Neuro Oncol | 2019 |
| 30169876 | Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. | Neuro-Oncology | 2019 |
| 30368015 | Unusual Radiographic Presentation of Intracranial Mature Teratoma and Resection via Supraorbital Approach. | World Neurosurg | 2019 |
| 31287992 | A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor. | Cancer Cell | 2019 |
| 29789890 | Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary? | Pediatr Radiol | 2018 |
| 35135163 | Year 1 in the Molecular Era of Pediatric Brain Tumor Diagnosis: Application of Universal Clinical Targeted Sequencing in an Unselected Cohort of Children. | JCO Precis Oncol | 2018 |
| 30019219 | Heterogeneity within the PF-EPN-B ependymoma subgroup. | Acta Neuropathol | 2018 |
| 30349086 | A biobank of patient-derived pediatric brain tumor models. | Nat Med | 2018 |
| 30006355 | Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations. | Mol Cancer Res | 2018 |
| 30049282 | Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry. | Acta Neuropathol Commun | 2018 |
| 30332335 | Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial. | J Clin Oncol | 2018 |
| 29173061 | Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations. | Pediatr Dev Pathol | 2018 |
| 29750396 | A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. | Pediatr Blood Cancer | 2018 |
| 29746225 | Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. | J Clin Oncol | 2018 |
| 29741745 | Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. | Neuro Oncol | 2018 |